Riverbank Capital Securities
3
12M
2
0.18
0.33
- Stages of investment
- Areas of investment
Summary
Riverbank Capital Securities is the famous VC, which was founded in 2012. The leading representative office of defined VC is situated in the New York. The venture was found in North America in United States.
This Riverbank Capital Securities works on 4 percentage points more the average amount of lead investments comparing to the other organizations. The top amount of exits for fund were in 2014. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is generally included in less than 2 deals every year. The top activity for fund was in 2007.
For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most popular portfolio startups of the fund, we may highlight Kite Pharma, Tigris Pharmaceuticals. The fund has no exact preference in a number of founders of portfolio startups. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. Among the most successful fund investment fields, there are Pharmaceutical, Medical.
The overall number of key employees were 1.
The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Riverbank Capital Securities, startups are often financed by Wexford Capital, NGN Capital. The meaningful sponsors for the fund in investment in the same round are Wexford Capital, Two River, Sonostar Capital Partners. In the next rounds fund is usually obtained by Two River, Sonostar Capital Partners, Arie Belldegrun.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 0
- Rounds per year
- 0.18
- Follow on index
- 0.33
- Investments by industry
- Health Care (2)
- Pharmaceutical (2)
- Biotechnology (2)
- Investments by region
-
- United States (2)
- Peak activity year
- 2011
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Tigris Pharmaceuticals | 17 Jan 2007 | Biotechnology, Health Care, Pharmaceutical | Early Stage Venture | 16M | United States, Florida |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.